Voyager Therapeutics Price to Sales Ratio 2014-2022 | VYGR
Historical PS ratio values for Voyager Therapeutics (VYGR) over the last 10 years. The current P/S ratio for Voyager Therapeutics as of July 01, 2022 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Voyager Therapeutics P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2022-07-01 |
6.08 |
|
7.26 |
| 2022-03-31 |
7.62 |
$0.84 |
9.09 |
| 2021-12-31 |
2.71 |
$0.99 |
2.73 |
| 2021-09-30 |
2.63 |
$0.42 |
6.21 |
| 2021-06-30 |
4.13 |
$3.51 |
1.18 |
| 2021-03-31 |
4.71 |
$4.25 |
1.11 |
| 2020-12-31 |
7.15 |
$4.57 |
1.57 |
| 2020-09-30 |
10.67 |
$5.30 |
2.01 |
| 2020-06-30 |
12.62 |
$2.73 |
4.62 |
| 2020-03-31 |
9.15 |
$3.17 |
2.89 |
| 2019-12-31 |
13.95 |
$2.84 |
4.92 |
| 2019-09-30 |
17.21 |
$1.99 |
8.65 |
| 2019-06-30 |
27.22 |
$1.50 |
18.17 |
| 2019-03-31 |
19.14 |
$0.36 |
52.58 |
| 2018-12-31 |
9.40 |
$0.24 |
39.52 |
| 2018-09-30 |
18.92 |
$0.41 |
45.92 |
| 2018-06-30 |
19.54 |
$0.39 |
50.00 |
| 2018-03-31 |
18.79 |
$0.36 |
52.83 |
| 2017-12-31 |
16.60 |
$0.38 |
43.37 |
| 2017-09-30 |
20.59 |
$0.24 |
86.02 |
| 2017-06-30 |
8.96 |
$0.33 |
27.50 |
| 2017-03-31 |
13.24 |
$0.43 |
30.94 |
| 2016-12-31 |
12.74 |
$0.56 |
22.60 |
| 2016-09-30 |
12.01 |
$1.65 |
7.29 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.234B |
$0.037B |
|
Voyager Therapeutics, Inc. is a gene therapy company. It focuses on the development of treatments for patients suffering from severe diseases of the central nervous system. Its pipeline includes VY-AADC01, which is in Phase 1b clinical trials for treatment of Parkinson's disease and preclinical programs comprise VY-SOD101 for a monogenic form of amyotrophic lateral sclerosis, VY-FXN01 for Friedreich ataxia and VY-HTT01 for Huntington's disease as well as VY-SMN101 for neuromuscular disease. Voyager Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.
|
